8h
Novo Nordisk slides as Ozempic pill fails to slow Alzheimer’s disease progression in large trials
Novo Nordisk (NVO) fell nearly 10% in U.S. premarket trading on Monday after the Danish drugmaker said a pill version of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback